The Helsinn model is based on three pillars: in-licensing, developing a product and making it available by obtaining the marketing authorization on international markets, and subsequently out-licensing it through a network of highly qualified partners worldwide.

In order to get access to the pharmaceutical market, a strong compliance system is required.

Helsinn Group has built a fully integrated compliance system based on a strong Quality Assurance System that guarantees full respect of every Good Laboratory Practice (GLP) requirement, a Regulatory Affairs department able to coordinate filings on a worldwide basis and a Drug Safety Unit department which coordinates post marketing surveillance activities for all of its partners around the world.

Moreover, special attention is paid to the growth of our pipeline with a strong Intellectual Protection management system, from technological platforms to product patents. Helsinn’s proprietary trade names are also offered to our partners for the various markets.

However, access also means taking care of pharmacoeconomic aspects in order to make pharmaceuticals available to patients and social partners with a balanced price. A newly created department will contribute to this valuable effort.

The Art of Access is the Art of Compliance, another of Helsinn’s ethical contribution to patients’ health, safety and quality of life.